BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV‐Infected Patients

AIDS Research and Treatment · Published 2025-01-01 · DOI 10.1155/arat/8818830

Authors being retrieved — see the publisher record. https://doi.org/10.1155/arat/8818830

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year
2025

Related articles